We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$138M
AUM Growth
-$6.49M
Cap. Flow
-$11.1M
Cap. Flow %
-8%
Top 10 Hldgs %
47.06%
Holding
111
New
11
Increased
35
Reduced
32
Closed
24

Top Buys

Rank Stock Value
1
PTEN icon
Patterson-UTI
PTEN
+$7.78M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$3.91M
3
INTC icon
Intel
INTC
+$3.72M
4
EWQ icon
iShares MSCI France ETF
EWQ
+$1.74M
5
EWU icon
iShares MSCI United Kingdom ETF
EWU
+$1.7M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$4.7M
2
UTEK
Ultratech Inc.
UTEK
+$4.61M
3
JCI icon
Johnson Controls International
JCI
+$2.15M
4
MPC icon
Marathon Petroleum
MPC
+$2.12M
5
AGN
Allergan plc
AGN
+$2.09M

Sector Composition

Rank Sector Weight
1 Technology 22.62%
2 Energy 20.47%
3 Healthcare 19.39%
4 Materials 5.38%
5 Industrials 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
101
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-101,950
Closed -$311K
TGT icon
102
Target
TGT
$65.6B
– –
-6,150
Closed -$444K
WSM icon
103
Williams-Sonoma
WSM
$26.9B
– –
-14,580
Closed -$353K
XRX icon
104
Xerox
XRX
$386M
– –
-19,544
Closed -$450K
NBL
105
DELISTED
Noble Energy, Inc.
NBL
– –
-10,000
Closed -$381K
AGN
106
DELISTED
Allergan plc
AGN
– –
-9,944
Closed -$2.09M
EGN
107
DELISTED
Energen
EGN
– –
-4,000
Closed -$231K
GST
108
DELISTED
Gastar Exploration Inc.
GST
– –
-23,000
Closed -$36K
UTEK
109
DELISTED
Ultratech Inc.
UTEK
– –
-192,035
Closed -$4.61M
1 2 3 4
5

Similar funds

AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $390M AUM 16.72% 1-Year Est. Return
P8IP
Pier 88 Investment Partners San Francisco, California $390M AUM 10.13% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
S
SimplyRich Carlsbad, California $391M AUM 24.42% 1-Year Est. Return
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return

Sicart Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Sicart Associates held 111 positions worth $138M, down 4.5% from $145M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sicart Associates withdrew a net $11.1M in Q1 2017, closing 24 positions and reducing 32 holdings. Its most notable exit was PTC Therapeutics, an estimated $4.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Sicart Associates opened a new position in iShares MSCI France ETF worth $1.81M.

  • Sicart Associates's largest Q1 2017 buy was iShares MSCI France ETF: 68,450 shares worth $1.81M.
  • Sicart Associates added most to Patterson-UTI in Q1 2017, an estimated $7.78M increase.
  • Sicart Associates's biggest Q1 2017 reduction was Weyerhaeuser, cutting an estimated $1.79M.
  • Sicart Associates fully exited PTC Therapeutics in Q1 2017, selling an estimated $4.7M.
  • Sicart Associates's ten largest holdings make up 47% of its $138M portfolio in Q1 2017.
  • Sicart Associates opened 11 new positions and closed 24 in Q1 2017.
  • Sicart Associates's portfolio value fell 4.5% quarter-over-quarter to $138M.

Based on Sicart Associates's 13F filing for Q1 2017, filed 10 Apr 2017.